Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

U.S. COVID-19 immunization rollout expands as officials avow vaccine's safety

Published 12/15/2020, 07:57 AM
Updated 12/15/2020, 05:40 PM
© Reuters. Five doses of COVID-19 vaccine is held by SPC Angel Laureano at the Walter Reed National Military Medical Center in Bethesda

© Reuters. Five doses of COVID-19 vaccine is held by SPC Angel Laureano at the Walter Reed National Military Medical Center in Bethesda

By Eduardo Muñoz

NEWARK, N.J. (Reuters) - The United States expanded its rollout of the newly approved COVID-19 vaccine to hundreds of additional distribution centers on Tuesday, inoculating thousands more healthcare workers in a mass immunization expected to reach the general public in the coming months.

Distribution of the vaccine developed by Pfizer Inc (NYSE:PFE) and German partner BioNTech SE (NASDAQ:BNTX) began on Monday, three days after it won U.S. emergency-use authorization, opening a new front in the battle against a pandemic claiming more than 2,400 U.S. lives a day.

Political leaders and medical authorities have launched a two-pronged media blitz avowing the safety of the vaccines while urging Americans to remain diligent about social distancing and mask-wearing until inoculations become widely available.

"As a polio survivor, I am a huge supporter of vaccinations. Whenever my turn comes, I will absolutely take the vaccine and do my part to reassure anyone who’s doubtful. It’s the right thing to do for yourself, for your family, and for the country," Senate Republican Leader Mitch McConnell said on Twitter.

At University Hospital in Newark, New Jersey, emergency room nurse Maritza Beniquez on Tuesday became the first person in that state to receive the vaccine in one of numerous such made-for-TV moments playing out across the country.

"I couldn't wait for this moment to hit New Jersey. I couldn't wait for it to hit the U.S.," Beniquez said as she was vaccinated with Governor Phil Murphy looking on.

Initial doses have been earmarked for doctors, nurses and other front-line medical professionals, along with residents and staff of nursing homes. Other essential workers, senior citizens and individuals with chronic medical conditions will be next in line.

It will take several months, perhaps until late spring, before vaccines can be obtained on demand by the public at large, U.S. officials have said.

In the meantime, a surge of infections and hospitalizations - approaching 111,000 patients in treatment on Tuesday - continued to strain healthcare systems to the brink of collapse in cities and rural areas across the country.

Nationwide, the highly contagious respiratory virus has killed 301,085 people and infected at least 16.5 million as of Monday, according to a Reuters tally of official data.

REFRIGERATOR UNITS, BODY BAGS

In California, where many hospitals had little or no capacity available in their intensive care units, the state has ordered scores of refrigerator storage trailers for corpses and distributed 5,000 body bags to San Diego, Los Angeles and Inyo counties, Governor Gavin Newsom said.

Newsom said the state also has activated mass-fatality compacts among county coroners and opened discussions with the federal government about sending a military medical ship back to the shores of the hard-hit state.

A bipartisan group of seven governors - from Illinois, Michigan, Indiana, Kentucky, Minnesota, Ohio and Wisconsin - released a joint video on social media on Tuesday urging residents to avoid unnecessary travel and social gatherings outside their households "until we eradicate this virus once and for all."

Another vaccine, from Moderna (NASDAQ:MRNA) Inc, appeared set for regulatory authorization this week after U.S. Food and Drug Administration staff endorsed it as safe and effective in documents released on Tuesday. Similar to the Pfizer vaccine, it requires two doses several weeks apart.

By late on Monday, shipments of the Pfizer vaccine, which requires sub-Arctic-level refrigeration, had arrived at nearly all of the 145 U.S. distribution sites pre-selected to receive the initial batch of doses.

A second round of shipments went out on Tuesday destined for 425 more distribution hubs and a third round was headed for 66 additional sites on Wednesday. In all, U.S. officials aim to get 2.9 million doses delivered by week's end.

In addition to the logistical challenges posed by an inoculation program of unparalleled scope - surpassing the childhood polio immunization campaign of the 1950s and '60s - health authorities face the monumental task of overcoming widespread skepticism about vaccines in general.

Some Americans believe the pandemic is a hoax and reject public health guidelines to wear masks and avoid crowds. Only 61% of respondents in a recent Reuters/Ipsos poll said they were open to getting vaccinated.

While most vaccines take years to develop, the Pfizer vaccine arrived less than a year after the illness was traced to a market in Wuhan, China, late last year.

"People understandably are skeptical about the speed, but we have to keep emphasizing speed means the science was extraordinary," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told ABC News' "Good Morning America" on Tuesday.

The pandemic has wreaked economic havoc as states and localities imposed sweeping stay-at-home orders and closed businesses to tamp down the contagion, putting millions out of work.

© Reuters. Five doses of COVID-19 vaccine is held by SPC Angel Laureano at the Walter Reed National Military Medical Center in Bethesda

In Washington, McConnell told reporters lawmakers would not adjourn for the year until they have agreed on a fresh package of coronavirus relief for the unemployed and small businesses, which he hoped could be attached to a larger government funding bill.

Latest comments

If the virus has already infected you, there's an incredibly high chance you now have a strong immunity for life against SARS COV 2. People who were infected by SARS 17 years ago, still have the T cell immunity and antibodies to successfully fight off this latest virus. So, if you've been infected with either of these viruses, there's really no point in getting the vaccine. This is not being mentioned at all in the mainstream media. They seem to want to vaccinate everyone even though they already have strong immunity against the virus. There have only been five confirmed cases to date where someone who was infected earlier in the year was infected again and became ill - out of over 800 million people worldwide. Our bodies' natural immune systems are incredibly effective if we're fit and healthy, eat well, have plenty of vit D in our bodies and don't have other major comorbidities.
What an elitist headline.
To be clear, the headline seems to have changed from earlier in the day. It previously said something along the lines of...U.S. trying to 'educate' skeptics. As if skeptics who rightly question the insanity going on before their eyes are simply uneducated fools.
new strain of virus discovered in the UK. no guarantee that the vaccine will be effective against it.
I know Coronavirus is for real and am taking reasonable precautions. However, I've got a real problem injecting new mRNA tech into my body that will alter my genetic code. Seems like my creator might have a problem with that too. The world is in need of repentance right now. Wake up call.
You can take the vaccine if you want to. Can also take this c19study.com . your body your choice.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.